All articles tagged with #c difficile
Originally Published 26 days ago — by SciTechDaily
Researchers in Leiden have developed EVG7, a potent low-dose antibiotic that effectively targets C. difficile infections while preserving beneficial gut bacteria, reducing relapse risk and potentially limiting resistance, with human trials possible in a few years.
Originally Published 2 years ago — by Gizmodo
The FDA has approved Vowst, an oral capsule containing beneficial bacteria derived from human fecal matter, to treat recurrent infections of Clostridioides difficile by balancing out the gut microbiome. Vowst was approved on the basis of two studies conducted in the U.S. and Canada, including a randomized, double-blinded placebo-controlled trial. The drug is intended to be used in conjunction with antibiotics to prevent recurrent C. difficile infections and is taken four capsules at a time daily for three days.